Adial

ADIL NASDAQ
2.020
+0.040
+2.02%
Closed 16:00 07/16 EDT
Open
1.990
Prev Close
1.980
High
2.150
Low
1.990
Volume
91.54K
Avg Vol (3M)
75.64K
52 Week High
9.44
52 Week Low
1.106
% Turnover
0.90%
Market Cap
20.65M
1D
5D
1M
3M
1Y
5Y

Company Profile

Adial Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of a therapeutic agent for the treatment of alcohol use disorder (AUD). Its lead drug product is AD04. AD04 is a selective serotonin-3 antagonist. AD04 can also be used for the treatment of other addictive disorders, such as obesity, smoking, and drug addiction. The Company has completed a Phase-II clinical trials of AD04.
MORE >

Recently

Name
Price
%Change